Who
Timothy Williams
EVP and Chief Legal Officer
Company insider
Files Form 4 as: EVP and Chief Legal Officer, Geron; SVP & General Counsel, Vanda Pharmaceuticals.
In numbers
- Trades disclosed
- 39
- Buys
- 0
- Sells
- 17
- Bought
- $0
- Sold
- $1.9M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 13 Aug 2018
- Last trade
- 13 Apr 2026
- Last filed
- 14 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 13 Apr 2026filed 14 Apr 2026 | GERN Geronoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,500,000 at $0.00 | filing |
| 13 Apr 2026filed 14 Apr 2026 | GERN Geronoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,500,000 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | VNDA Vanda PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $351K42,434 at $8.27 | filing |
| 2 Mar 2026filed 4 Mar 2026 | VNDA Vanda PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $351K42,434 at $8.27 | filing |
| 18 Feb 2026filed 19 Feb 2026 | VNDA Vanda PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
| 18 Feb 2026filed 19 Feb 2026 | VNDA Vanda PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
| 1 Mar 2025filed 4 Mar 2025 | VNDA Vanda PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $128K26,941 at $4.76 | filing |
| 18 Feb 2025filed 20 Feb 2025 | VNDA Vanda PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
| 5 Mar 2024filed 6 Mar 2024 | VNDA Vanda PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $37K8,941 at $4.18 | filing |
| 4 Mar 2024filed 6 Mar 2024 | VNDA Vanda PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $36K8,147 at $4.41 | filing |
| 16 Feb 2024filed 21 Feb 2024 | VNDA Vanda PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
| 13 Jun 2023filed 15 Jun 2023 | VNDA Vanda PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $96K14,600 at $6.56 | filing |
| 3 Mar 2023filed 6 Mar 2023 | VNDA Vanda PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $52K8,301 at $6.25 | filing |
| 2 Mar 2023filed 6 Mar 2023 | VNDA Vanda PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $53K8,437 at $6.24 | filing |
| 16 Feb 2023filed 21 Feb 2023 | VNDA Vanda Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —77,500 at $0.00 | filing |
| 16 Feb 2023filed 21 Feb 2023 | VNDA Vanda PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —32,700 at $0.00 | filing |
| 15 Dec 2022filed 16 Dec 2022 | VNDA Vanda PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $56K8,000 at $7.01 | filing |
| 15 Aug 2022filed 17 Aug 2022 | VNDA Vanda PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $38K3,689 at $10.42 | filing |
| 15 Aug 2022filed 17 Aug 2022 | VNDA Vanda PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $47K4,611 at $10.21 | filing |
| 2 Mar 2022filed 2 Mar 2022 | VNDA Vanda PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $134K12,060 at $11.09 | filing |
News
City of Monroe announces appointment of Fire Chief Timothy Williamskedm.org · 17 Sep 2026Gov. Landry reappoints Timothy Williams as Monroe fire chiefknoe.com · 16 Sep 2026Vanda Pharmaceuticals Provides Update on VQW-765 Clinical Development ProgramVNDA · prnewswire.com · 14 Oct 2026
2 headlines in the last 90 days name Timothy Williams; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.